A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health
for Sudan Virus Disease
3 locations incl. Washington D.C.
Sponsor: International AIDS Vaccine Initiative
Sex: All·Age: 18 - 50·Accepts healthy volunteers
Code: NCT07565090·Phase 1·Recruiting·Listed May 2026